Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer
Clinical Cancer Research, 09/15/09
Arredouani MS et al. – The findings that SIM2 is selectively expressed in PCa, that human HLA–A2.1–restricted SIM2 epitopes induce specific T cells in vivo, and that anti–SIM2 antibodies are detectable in PCa patients' sera implicate SIM2 as a PCa–associated antigen that is a suitable potential target for PCa immunotherapy.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Two founder BRCA2 mutations predispose to breast cancer in young women
Breast Cancer Research and Treatment, 12/07/09
SULT1A1 R213H polymorphism and breast cancer risk: A meta-analysis based on 8,454 cases and 11,800 controls
Breast Cancer Research and Treatment, 12/07/09
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Blood pressure and risk of prostate cancer: Cohort Norway (CONOR)
Cancer Causes and Control, 12/07/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/07/09
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


